Drugs / TC-G203
last change Dec 2025 re-read 2 minutes ago

TC-G203

Cell therapy

Developed for
hepatocellular carcinoma
Investigated by
Beijing GoBroad Hospital

Trials 1 · a red edge is where a trial was stopped

20262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT07242417 Dec 2025 → Dec 2026 expected hepatocellular carcinoma Beijing GoBroad Hospital Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TC-G203 ClinicalTrials.gov intervention name — accepted as the source's own label NCT07242417
Modality Cell therapy “TC-G203 CAR-T cells” NCT07242417